Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeted α-therapy in non-prostate malignancies

European Journal of Nuclear Medicine and Molecular Imaging(2021)10.1007/s00259-021-05405-0Source: DataRank Database

Targeted α-therapy in non-prostate malignancies is a research paper published in European Journal of Nuclear Medicine and Molecular Imaging (2021). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.14)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Patrick M. Colletti ORCID,Hossein Jadvar ORCID

Live enrichment

PubMed:33993386 PMC:PMC11927099 OpenAlex:https://openalex.org/W3160647716

National Institutes of Health

Grant: R21-EB017568

National Institutes of Health

Grant: P30-CA014089

NCI NIH HHS

Grant: P30 CA014089

NIBIB NIH HHS

Grant: R21 EB017568

National Institutes of Health

Grant: 1R21EB017568-01A1

Pilot Human Studies of FMAU PET in Prostate Cancer

National Institutes of Health

Grant: 3P30CA014089-17S1

USC COMPREHENSIVE CANCER CENTER (CORE) SUPPORT

FWCI

1.14

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

greenLicense: Springer Nature TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11927099

publisherhttps://link.springer.com/content/pdf/10.1007/s00259-021-05405-0.pdf

publisherhttps://link.springer.com/article/10.1007/s00259-021-05405-0/fulltext.html

journalhttps://doi.org/10.1007/s00259-021-05405-0

Fields of Study

Radiopharmaceutical Chemistry and ApplicationsProstate Cancer Treatment and ResearchPeptidase Inhibition and Analysis03 medical and health sciences0302 clinical medicineHumansMaleProstatic NeoplasmsRadioisotopesRadiopharmaceuticals

MeSH Terms

HumansMaleProstatic NeoplasmsRadioisotopesRadiopharmaceuticals

Keywords

MedicineProstate cancerTargeted therapyCancerOncologyProstateMelanomaInternal medicineCancer researchAlphaClinicalPreclinicalMaleRadioisotopesHumansProstatic NeoplasmsRadiopharmaceuticals

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Targeted α-therapy in non-prostate malignancies

FAIR Checklist

Authors (2)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)